$Microsoft(MSFT)$  

The Hang Seng Index continues to extend its multi-session recovery, supported by strength in the tech, biotech, and IPO sectors. Key market hot spots driving today's action:  Big Tech & AI Capex (Alibaba, SMIC, Xiaomi): Tech names are rebounding following high-profile executive insider buying from Jack Ma and Joe Tsai. This has helped absorb market anxiety surrounding Alibaba’s HK$80B placement for AI infrastructure, driving renewed interest across contract chipmakers like SMIC and hardware names like Xiaomi.  Healthcare & Biotech Surges: The biotech sector is outperforming the broader market, fueled by strong H1 results from leaders like WuXi Biologics (+14.8%) alongside a rally in cancer-vaccine developers following global platform breakthroughs.

Ray Dalio’s call for a 10–15% allocation to gold aligns cleanly with current structural debt dynamics, but taking a full 15% position today overlooks the macro friction created by short-term real rates. While spot gold pushing to $4,647 reflects growing market concern over long-term fiscal sustainability and currency debasement, the move remains a tactical recovery below January's $5,608 peak rather than an unconstrained breakout—especially with hawkish central bank commentary and sticky inflation threatening to lift real yields. Rather than over-allocating upfront, building a 5–10% core hedge via GLD combined with selective exposure to operational leverage through gold miners like Newmont offers the optimal balance between long-term macro protection and downside risk management.

Michael Burry exiting Alibaba to rotate into JD.com highlights valid concerns over return on invested capital, as a 75% profit plunge driven by a $10.2B equity dilution and a 75% spike in quarterly capex ($9.98B) creates severe near-term margin friction. However, the CEO’s ~$4.98M insider purchase—combined with cloud revenue accelerating to 45% growth and AI product revenue delivering triple-digit gains—proves that AI infrastructure spending is an essential entry ticket to cloud reacceleration rather than a permanent drag. With 40%+ cloud growth and expanding segment EBITA margins (12%), waiting for post-earnings clarity will likely confirm that Alibaba’s short-term margin compression is laying the structural foundation for long-term cloud dominance.

While the $9.2B peak sales model for intismeran provides strong long-term validation for Moderna’s mRNA platform beyond COVID-19, chasing a 14% single-day pop driven by a broker upgrade from Underperform to Neutral carries high near-term risk. Without published Phase 3 trial specifics or signed commercial contracts, current pricing reflects speculative future potential while LTM revenue remains down 27.6% y/y at $2.23B. The safer play is rotating into Merck, which split-funds the therapy and provides immediate downside protection via Keytruda cash flows, or simply waiting for detailed clinical data before building a core position in Moderna.

SanDisk closing lower (-0.83%) while Micron (+2.48%) and SK Hynix (+2.68%) rallied reflects its distinct product mix and crowded institutional ownership rather than a breakdown in fundamental memory demand. While SK Hynix and Micron command the high-margin High Bandwidth Memory (HBM) supply chains directly linked to NVIDIA's AI accelerators, SanDisk remains heavily exposed to consumer flash and enterprise NAND, making it the primary target for position trimming as traders reallocate capital into direct HBM pure-plays. Rather than chasing the initial pop, the optimal play is waiting for post-earnings clarity on gross margin sustainability—specifically watching whether upstream memory price hikes begin dampening buyer capex before stepping into SanDisk on a technical reset.

While Circle's structural divergence makes for a fascinating macro debate, Strategy remains the premier play here for pure beta. The 115% analyst target gap on Circle highlights how sensitive its reserve-interest model is to monetary policy—rate cuts shrink yield revenue even as volume expands. Strategy, by contrast, operates as a leveraged proxy for pure digital asset adoption, with Canaccord's upgraded $175 target reflecting a battle-tested balance sheet and direct tailwinds from Bitcoin breaching key resistance levels. For traders seeking direct upside from crypto market momentum, Strategy offers the cleanest directional exposure without the monetary policy drag weighing down stablecoin issuers.

With July core PCE running at 3.3% y/y and 0.2% m/m, sticky inflation combined with elevated long-end yields (10-year near 4.7%, 30-year above 5.2%) creates a tough macro backdrop where high-duration tech valuations face double pressure. For Chair Kevin Warsh's Jackson Hole keynote—centered on "Financial Innovation: Implications for Payments and Policy"—he is likely to avoid explicitly spoon-feeding near-term rate cut promises, leaving Bitcoin and digital assets best positioned to capture speculative momentum if he adopts a forward-looking stance on payment rails, tokenized deposits, and stablecoin frameworks. Gold continues to serve as a solid hedge against sticky inflation and long-term fiscal debt dynamics, while Equities will likely remain constrained by high discount rates until long-

NVIDIA's record Q2 revenue of $96.22B (+106% YoY) and strong Q3 guidance of $108B prove that AI compute demand remains insatiable, but the temporary compression of gross margins to 71–72% in Q4 highlights the rising costs of HBM memory supply. Rather than signaling structural weakness, this margin dip simply reflects component pricing dynamics while the Vera Rubin architecture scales up for full production. Historically, NVIDIA has seen post-earnings profit-taking despite stellar beats, making the broader supply chain ecosystem—particularly memory partners like SK Hynix and Micron—the more compelling play for immediate upside as hardware rollout accelerates.

NVIDIA ($NVDA): The biggest story of the day. NVDA reported Q2 revenue of $96.22B (up 106% YoY) and EPS of $2.22, topping Street estimates. After-hours shares spiked over 4% on strong Q3 guidance of $108B and CEO Jensen Huang confirming AI demand continues to outpace supply.

$GOOG 20270219 330.0 PUT$ 

$QQQ 20270219 705.0 PUT$ 

$MSFT 20261016 495.0 PUT$ 

$Microsoft(MSFT)$  

Shortterm market pullbacks don't change Microsoft’s enterprise dominance. Enterprise Copilot adoption is scaling, and Azure remains a juggernaut. continue buying long

$Microsoft(MSFT)$  

$GOOG 20261218 330.0 PUT$ 

$Microsoft(MSFT)$  

$Microsoft(MSFT)$  

$Microsoft(MSFT)$